Cargando…

The odds of neoplasia in dogs with and without diabetes mellitus

BACKGROUND: Increased risk of neoplasia in humans with diabetes mellitus (DM) is well documented. It is unknown if dogs with DM have increased risk of neoplasia. OBJECTIVE: Determine if dogs with DM have an overall increased risk of neoplasia and risk for specific forms of neoplasia compared to dogs...

Descripción completa

Detalles Bibliográficos
Autores principales: Manoharan, Sindumani A., Hess, Rebecka S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965209/
https://www.ncbi.nlm.nih.gov/pubmed/35081271
http://dx.doi.org/10.1111/jvim.16370
_version_ 1784678379907186688
author Manoharan, Sindumani A.
Hess, Rebecka S.
author_facet Manoharan, Sindumani A.
Hess, Rebecka S.
author_sort Manoharan, Sindumani A.
collection PubMed
description BACKGROUND: Increased risk of neoplasia in humans with diabetes mellitus (DM) is well documented. It is unknown if dogs with DM have increased risk of neoplasia. OBJECTIVE: Determine if dogs with DM have an overall increased risk of neoplasia and risk for specific forms of neoplasia compared to dogs without DM. ANIMALS: Seven hundred dogs with DM and 700 breed, age, and sex‐matched dogs without DM, examined during the same years. METHODS: Retrospective case‐control study. Odds ratios (OR), corresponding 95% confidence intervals (CI), and P‐values were calculated using conditional logistic regression to determine if dogs with DM had increased odds of developing neoplasia compared to dogs without DM. RESULTS: The overall odds of developing neoplasia were not significantly different in dogs with and without DM. However, dogs with DM had significantly higher odds of developing an adrenal mass (OR, 4; 95% CI, 1.1‐14.2; P = .03) compared to dogs without DM. The odds of developing a splenic mass in dogs with DM (OR, 1.2; 95% CI, 0.99‐1.39) were increased compared to dogs without DM, but this difference was not significant (P = .07). CONCLUSIONS AND CLINICAL IMPORTANCE: Dogs with DM may be at increased risk for adrenal neoplasia. Awareness of this risk can facilitate early diagnosis of this life‐threatening comorbidity. Larger studies are needed to confirm these findings.
format Online
Article
Text
id pubmed-8965209
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-89652092022-04-05 The odds of neoplasia in dogs with and without diabetes mellitus Manoharan, Sindumani A. Hess, Rebecka S. J Vet Intern Med SMALL ANIMAL BACKGROUND: Increased risk of neoplasia in humans with diabetes mellitus (DM) is well documented. It is unknown if dogs with DM have increased risk of neoplasia. OBJECTIVE: Determine if dogs with DM have an overall increased risk of neoplasia and risk for specific forms of neoplasia compared to dogs without DM. ANIMALS: Seven hundred dogs with DM and 700 breed, age, and sex‐matched dogs without DM, examined during the same years. METHODS: Retrospective case‐control study. Odds ratios (OR), corresponding 95% confidence intervals (CI), and P‐values were calculated using conditional logistic regression to determine if dogs with DM had increased odds of developing neoplasia compared to dogs without DM. RESULTS: The overall odds of developing neoplasia were not significantly different in dogs with and without DM. However, dogs with DM had significantly higher odds of developing an adrenal mass (OR, 4; 95% CI, 1.1‐14.2; P = .03) compared to dogs without DM. The odds of developing a splenic mass in dogs with DM (OR, 1.2; 95% CI, 0.99‐1.39) were increased compared to dogs without DM, but this difference was not significant (P = .07). CONCLUSIONS AND CLINICAL IMPORTANCE: Dogs with DM may be at increased risk for adrenal neoplasia. Awareness of this risk can facilitate early diagnosis of this life‐threatening comorbidity. Larger studies are needed to confirm these findings. John Wiley & Sons, Inc. 2022-01-26 2022-03 /pmc/articles/PMC8965209/ /pubmed/35081271 http://dx.doi.org/10.1111/jvim.16370 Text en © 2022 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals LLC on behalf of American College of Veterinary Internal Medicine. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle SMALL ANIMAL
Manoharan, Sindumani A.
Hess, Rebecka S.
The odds of neoplasia in dogs with and without diabetes mellitus
title The odds of neoplasia in dogs with and without diabetes mellitus
title_full The odds of neoplasia in dogs with and without diabetes mellitus
title_fullStr The odds of neoplasia in dogs with and without diabetes mellitus
title_full_unstemmed The odds of neoplasia in dogs with and without diabetes mellitus
title_short The odds of neoplasia in dogs with and without diabetes mellitus
title_sort odds of neoplasia in dogs with and without diabetes mellitus
topic SMALL ANIMAL
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965209/
https://www.ncbi.nlm.nih.gov/pubmed/35081271
http://dx.doi.org/10.1111/jvim.16370
work_keys_str_mv AT manoharansindumania theoddsofneoplasiaindogswithandwithoutdiabetesmellitus
AT hessrebeckas theoddsofneoplasiaindogswithandwithoutdiabetesmellitus
AT manoharansindumania oddsofneoplasiaindogswithandwithoutdiabetesmellitus
AT hessrebeckas oddsofneoplasiaindogswithandwithoutdiabetesmellitus